Drug class

COVID-19 (SARS-CoV-2) Vaccines

COVID-19 (SARS-CoV-2) vaccines constitute a biological class of active immunizing agents designed to prevent coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2. Read more about COVID-19 (SARS-CoV-2) Vaccines

8 drugs in this class 3 manufacturers

Advertisement

Drugs in COVID-19 (SARS-CoV-2) Vaccines

Showing 1–8 of 8 drugs

Filter & compare in the drug finder → Opens the drug finder with COVID-19 (SARS-CoV-2) Vaccines preselected. Add indication or manufacturer filters there.

About COVID-19 (SARS-CoV-2) Vaccines.

COVID-19 (SARS-CoV-2) vaccines constitute a biological class of active immunizing agents designed to prevent coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2.

Utilizing platforms such as messenger RNA, recombinant protein subunits, or viral vectors, these vaccines introduce or instruct host cells to transiently express antigenic targets—primarily the viral spike glycoprotein—stimulating robust humoral neutralizing antibody and cell-mediated immune responses.

Their principal therapeutic role is the pre-exposure prophylaxis of SARS-CoV-2 infection, substantially reducing the risks of symptomatic infection, severe lower respiratory disease, hospitalization, and mortality.